Cytophage Technologies Balance Sheet Health
Financial Health criteria checks 4/6
Cytophage Technologies has a total shareholder equity of CA$5.3M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$7.3M and CA$2.0M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | CA$3.67m |
| Equity | CA$5.26m |
| Total liabilities | CA$2.05m |
| Total assets | CA$7.31m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CYTO's short term assets (CA$4.2M) exceed its short term liabilities (CA$709.9K).
Long Term Liabilities: CYTO's short term assets (CA$4.2M) exceed its long term liabilities (CA$1.3M).
Debt to Equity History and Analysis
Debt Level: CYTO is debt free.
Reducing Debt: CYTO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYTO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CYTO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 28.4% each year